Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 12:19 pm Purchase | 2024-09-30 | 13G | Inozyme Pharma, Inc. INZY | Eventide Asset Management, LLC | 4,134,436 6.440% | 954,599 (+30.02%) | Filing History |
| 2024-11-14 12:18 pm Sale | 2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX | Eventide Asset Management, LLC | 3,332,005 5.030% | -298,008 (-8.21%) | Filing History |
| 2024-11-14 12:17 pm Purchase | 2024-09-30 | 13G | Nektar Therapeutics NKTR | Eventide Asset Management, LLC | 9,400,000 5.110% | 9,400,000 (New Position) | Filing History |
| 2024-11-06 2:47 pm Sale | 2024-10-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Eventide Asset Management, LLC | 7,090,108 9.970% | -4,469,867 (-38.67%) | Filing History |
| 2024-08-09 09:43 am Sale | 2024-07-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Eventide Asset Management, LLC | 2,192,211 6.650% | -810,620 (-27.00%) | Filing History |
| 2024-02-14 12:49 pm Purchase | 2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM | Eventide Asset Management, LLC | 2,693,581 5.780% | 636,581 (+30.95%) | Filing History |
| 2024-02-14 12:43 pm Sale | 2023-12-31 | 13G | Annexon, Inc. ANNX | Eventide Asset Management, LLC | 0 0.000% | -3,626,508 (Position Closed) | Filing History |
| 2024-02-14 12:36 pm Sale | 2023-12-31 | 13G | Xometry, Inc. XMTR | Eventide Asset Management, LLC | 5,727,770 12.620% | -2,569 (-0.04%) | Filing History |
| 2024-02-14 12:29 pm Sale | 2023-12-31 | 13G | VectivBio Holding AG VECT | Eventide Asset Management, LLC | 0 0.000% | -3,405,644 (Position Closed) | Filing History |
| 2024-02-14 12:21 pm Unchanged | 2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Eventide Asset Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 12:18 pm Purchase | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Eventide Asset Management, LLC | 4,529,997 8.300% | 1,379,997 (+43.81%) | Filing History |
| 2024-02-14 12:15 pm Unchanged | 2023-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN | Eventide Asset Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 12:04 pm Purchase | 2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL | Eventide Asset Management, LLC | 2,630,478 8.070% | 885 (+0.03%) | Filing History |
| 2024-02-14 12:02 pm Sale | 2023-12-31 | 13G | 908 Devices Inc. MASS | Eventide Asset Management, LLC | 1,430,995 4.420% | -799,670 (-35.85%) | Filing History |
| 2024-02-14 11:59 am Purchase | 2023-12-31 | 13G | Korro Bio, Inc. KRRO | Eventide Asset Management, LLC | 546,325 6.830% | 546,325 (New Position) | Filing History |
| 2024-02-14 11:54 am Purchase | 2023-12-31 | 13G | Inozyme Pharma, Inc. INZY | Eventide Asset Management, LLC | 3,179,837 5.150% | 3,179,837 (New Position) | Filing History |
| 2024-02-14 11:48 am Purchase | 2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Eventide Asset Management, LLC | 3,630,013 6.640% | 3,630,013 (New Position) | Filing History |
| 2023-12-11 5:15 pm Purchase | 2023-11-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | Eventide Asset Management, LLC | 11,559,975 16.340% | 3,745,936 (+47.94%) | Filing History |
| 2023-12-11 5:14 pm Purchase | 2023-11-30 | 13G | Aura Biosciences, Inc. AURA | Eventide Asset Management, LLC | 5,802,682 11.820% | 3,551,314 (+157.74%) | Filing History |
| 2023-12-11 5:13 pm Purchase | 2023-11-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Eventide Asset Management, LLC | 3,002,831 11.930% | 3,002,831 (New Position) | Filing History |